This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Phase 1 Results

A Cooperative Study

JAMA. 1970;214(12):2163-2172.

Abstract
In a randomized, national cooperative trial, urokinase and subsequent heparin sodium therapy, when compared to heparin therapy alone, significantly accelerated the resolution rate of pulmonary thromboemboli at 24 hours as shown by pulmonary arteriograms, lung scans, and right-sided pressure measurements. No significant differences in recurrence rate of pulmonary embolism or in the two-week mortality were observed. Bleeding, which occurred in 45% of patients receiving urokinase as contrasted to 27% in the heparin group, was the only complication of urokinase therapy. This increase in bleeding seen with urokinase was closely associated with the invasive procedures necessary to obtain the arteriographic and hemodynamic information. Because the urokinase regimen did not usually achieve complete or nearly complete thrombolysis, and because of its hemorrhagic property, further studies with urokinase in pulmonary thromboembolism are indicated before specific therapeutic recommendations can be made.

Author Affiliations
From the Urokinase Pulmonary Embolism Trial Study Group.

Footnotes
For a complete list of participants see page 2172.

Reprint requests to National Heart and Lung Institute, National Institutes of Health, 4A-03 Bldg 31, Bethesda, Md 20014 (Dr. Stengle).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Thrombolytic Therapy for Acute Pulmonary Embolism: A Critical Appraisal
Todd and Tapson
Chest 2009;135:1321-1329.
ABSTRACT | FULL TEXT  

Thrombolytic Therapy and Mortality in Patients With Acute Pulmonary Embolism
Ibrahim et al.
Arch Intern Med 2008;168:2183-2190.
ABSTRACT | FULL TEXT  

Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Kearon et al.
Chest 2008;133:454S-545S.
ABSTRACT | FULL TEXT  

Pulmonary Embolism: Prognostic CT Findings
Araoz et al.
Radiology 2007;242:889-897.
ABSTRACT | FULL TEXT  

When should we thrombolyse patients with pulmonary embolism? A systematic review of the literature
Harris and Meek
Emerg. Med. J. 2005;22:766-771.
ABSTRACT | FULL TEXT  

Antithrombotic Therapy for Venous Thromboembolic Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Buller et al.
Chest 2004;126:401S-428S.
ABSTRACT | FULL TEXT  

Invasive Approaches to Treatment of Venous Thromboembolism
Augustinos and Ouriel
Circulation 2004;110:I-27-I-34.
ABSTRACT | FULL TEXT  

Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism: A Meta-Analysis of the Randomized Controlled Trials
Wan et al.
Circulation 2004;110:744-749.
ABSTRACT | FULL TEXT  

The Impact of Right Ventricular Dysfunction on the Prognosis and Therapy of Normotensive Patients With Pulmonary Embolism
Kreit
Chest 2004;125:1539-1545.
ABSTRACT | FULL TEXT  

The Management of Venous Thromboembolic Disease in Older Adults
Rich
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2004;59:M34-41.
ABSTRACT | FULL TEXT  

Natural History of Venous Thromboembolism
Kearon
Circulation 2003;107:I-22-30.
ABSTRACT | FULL TEXT  

Diagnosis of pulmonary embolism
Kearon
CMAJ 2003;168:183-194.
ABSTRACT | FULL TEXT  

The Uncertain Role of Thrombolytic Therapy in the Treatment of Pulmonary Embolism
Dalen
Arch Intern Med 2002;162:2521-2523.
FULL TEXT  

Thrombolytic Therapy
Baker
CLIN APPL THROMB HEMOST 2002;8:291-314.
 

Massive Pulmonary Embolism During Pregnancy Successfully Treated With Recombinant Tissue Plasminogen Activator: A Case Report and Review of Treatment Options
Ahearn et al.
Arch Intern Med 2002;162:1221-1227.
FULL TEXT  

Major Pulmonary Embolism : Review of a Pathophysiologic Approach to the Golden Hour of Hemodynamically Significant Pulmonary Embolism
Wood
Chest 2002;121:877-905.
ABSTRACT | FULL TEXT  

Predictors of Survival After Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based, Cohort Study
Heit et al.
Arch Intern Med 1999;159:445-453.
ABSTRACT | FULL TEXT  

Elevated Expression of Urokinase-like Plasminogen Activator and Plasminogen Activator Inhibitor Type 1 During the Vascular Remodeling Associated With Pulmonary Thromboembolism
Lang et al.
Arterioscler. Thromb. Vasc. Bio. 1998;18:808-815.
ABSTRACT | FULL TEXT  

Thrombolytic Therapy for Pulmonary Embolism: Is It Effective? Is It Safe? When Is It Indicated?
Dalen et al.
Arch Intern Med 1997;157:2550-2556.
ABSTRACT  

Improved Lung Function by Urokinase Infusion in Canine Lung Transplantation Using Non-Heart-Beating Donors
Umemori et al.
Ann. Thorac. Surg. 1995;59:1513-1518.
ABSTRACT | FULL TEXT  

Emergency Surgery in an Acutely 111 Hypotensive Patient with a Large, Mobile, Echogenic Right Sided, Intracavitary Cardiac Mass--A Case Report
Sheldon et al.
VASC ENDOVASCULAR SURG 1990;24:281-284.
ABSTRACT  

Acute on Chronic Respiratory Failure: Assessment and Management of Patients With COPD in the Emergent Setting
Schmidt and Hall
JAMA 1989;261:3444-3453.
ABSTRACT  

Diagnosis of Pulmonary Embolism
Fulkerson et al.
Arch Intern Med 1986;146:961-967.
ABSTRACT  

Cerebrovascular Complications of Streptokinase Infusion
Aldrich et al.
JAMA 1985;253:1777-1779.
ABSTRACT  

Streptokinase-Induced Subcapsular Hematoma of the Liver
Willis and Bailey
Arch Intern Med 1984;144:2084-2085.
ABSTRACT  

Streptokinase Salvage of Renal Function After Renal Vein Thrombosis
BURROW et al.
ANN INTERN MED 1984;100:237-238.
ABSTRACT  

Fibrinolytic Therapy Urokinase for Myocardial Infarction
Nakano
ANGIOLOGY 1983;34:654-673.
ABSTRACT  

Spontaneous Mediastinal Hemorrhage: A Complication of Intracoronary Streptokinase Infusion for Coronary Thrombosis
Singh et al.
Arch Intern Med 1983;143:562-563.
ABSTRACT  

The Use of Thrombolytic Agents: Choice of Patient, Drug Administration, Laboratory Monitoring
MARDER
ANN INTERN MED 1979;90:802-808.
ABSTRACT  

Thrombolytic Therapy: Agents, Indication, Clinical Performance, and Side Effects
Greul et al.
VASC ENDOVASCULAR SURG 1979;13:79-86.
 

Thrombolysis as an Alternative to Pulmonary Embolectomy
Porter
VASC ENDOVASCULAR SURG 1977;11:373-377.
 

Urokinase-Streptokinase Embolism Trial: Phase 2 Results
A Cooperative Study
JAMA 1974;229:1606-1613.
ABSTRACT  

The Urokinase-Pulmonary Embolism Trial
Sautter
JAMA 1974;227:1168-1169.
ABSTRACT  

Relationship of Fibrinolytic System to Postoperative Thrombotic Phenomena
Sautter et al.
Arch Surg 1973;107:292-296.
ABSTRACT  

Venous and Arterial Occlusive Disease Treated By Enzymatic Clot Lysis
LeVeen and Diaz
Arch Surg 1972;105:927-936.
ABSTRACT  

The Humoral Factor in Pulmonary Embolism
Hamilton and Nemir
Arch Surg 1972;105:593-598.
ABSTRACT  

Massive Acute Pulmonary Embolism: The Deceivingly Nonspecific Manifestations
Wenger et al.
JAMA 1972;220:843-844.
ABSTRACT  

Streptokinase Therapy for Thromboembolic Occlusive Vascular Disease
SHERRY
ANN INTERN MED 1971;74:437-440.
ABSTRACT